on
4th International Conference and Exhibition on Biologics and Biosimilars
October 26-28, 2015 Baltimore, USA
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Biosimilars 2015
Home
Gallery
Biosimilars 2015 Report

Biosimilars 2015 Report

OMICS International hosted the 4th International Conference and Exhibition on Biologics and Biosimilars at Double Tree by Hilton Hotel Baltimore, USA during October 26-28, 2015.The conference was designed around the theme of “ The future of Next Generation Biologics and Biosimilars”  and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering.

Biosimilars 2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars.

OMICS International would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Media Partners, Exhibitors and Covance Laboratories as sponsors of Biosimilars 2015:

Patrick Lucy, Pfenex Inc., USA
Kamali Chance, Quintiles Inc., USA
Christopher Leintz, Pfizer, USA

Mark A Emalfarb,  Dyadic Internatrional, USA

Sarfaraz K NIazi, Therapeutic Proteins International, USA

Angela Furlanetto, Dimock Stratton LLP, Canada


OMICS International on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours. 

OMICS International also took the privilege of felicitating Biosimilars 2015 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.

With the enormous feedback from the participants and supporters of Biosimilars 2015, OMICS International is glad to announce 5th European Biosimilars Congress during June 27-29, 2016 at Valencia, Spain and 6th International Conference and Exhibition on Biologics and Biosimilars through October 20-22, 2016 at Houston, USA



Expert Presentations
Gene Ransom III

MedChi

USA
Min Zhang

Fujifilm Diosynth Biotechnologies

USA
Ronald A Rader

Biotech Info Institute

USA
Mark Emalfarb

Dyadic International

USA
Kamali Chance

Quintiles

USA
Neil Schauer

Avaxia Biologics

USA
Raymond A Huml

Quintiles

USA
Dipti Gulati

PJI Biotech

USA
Roman T Drews

LFB

USA
Jill Myers

Momenta Pharmaceuticals

USA
Christopher Leintz

Pfizer Inc.

USA
Candida Fratazzi

Boston Biotech Clinical Research

USA
Samantha Little

Covance

USA
Gordon Bolger

Nucro Technics

Canada
Andy Upsall

BioOutsorce

UK
Sarfaraz K NIazi

Therapeutic Proteins International

USA
Mariana Babayeva

Touro College Of Pharmacy

USA
Conference Secretariat: Biosimilars 2015, Conference Series Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine , Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved